Researching what leads some individuals to age more slowly than the rest of the population could enable novel strategies for the treatment or prevention of aging-related chronic disease. Some genetic determinants have already been discovered in centenarians, and learning more about these factors could lead to therapies and treatments that improve quality and quantity of life. However, exceptional longevity, generally defined as survival to 85 years or older, is uncommon. Thus, there is the need to improve sample sizes to ensure scientific rigor. The Centenarian Family Research Study and Biorepository to Identify Determinants of Healthy Aging and Exceptional Longevity study formed to use multi-modal engagement to develop the world’s largest centenarian family registry and biorepository for systematic investigation of healthspan and exceptional longevity in humans.
The overarching goals of this coalition are to amass the world’s largest cohort of centenarians as well as their offspring who possess protective phenotypes related to aging compared to spouse controls. The scientific aims include:
The project is an observational cohort study that includes two phases. In the pilot feasibility phase, the study aims to enroll 250 centenarians and 500 offspring of centenarians and offspring’s spouses. In the scale up phase, 10,000 centenarians, as well as their offspring and offspring spouses if available, will be recruited according to the inclusion criteria:
The SuperAgers Family Study uses the following methods of data collection:
Participants using eConsent can manage their participation in the program through Participant Experience Manager, which includes the ability to download their consent and related information, and withdraw consent at any time.
Consent to recontact research participants is also an important element of the research initiative’s eConsent process. The study team contacts participants with periodic updates and opportunities to participate in studies of healthy aging and longevity and drug development activities.
Because of the unique needs of the centenarian population, the SuperAgers Family Study uses CATI features, part of Vibrent’s digital health research platform, to engage participants in contributing data when necessary. This approach helps to increase the eConsent and survey completion volume for such participants.
CATI is a structured system of data collection by telephone that allows trained program staff to verify participant identity and verbal authorization to proceed, then complete the collection of participant data. Once a CATI session is completed, the participant has access to information submitted within their account.
With a focus on creating a family registry and biorepository for the centenarian population, the SuperAgers Family Study also collects the family link among offspring and their related centenarian.
Research participants can eConsent to share their EHR data through HL7 FHIR subject EHR exchange.
The SuperAgers Family Study aims to perform genome and exome-wide sequencing of samples and to perform association analyses of all genotypes across the genome (genome-wide) with all clinical phenotypes from survey and EHR data (phenome-wide).
This automated process makes the protocol non-invasive and user-friendly for this older population.
This portal runs on Vibrent Participant Experience Manager, and provides participants access to capabilities that include:
The study recruits research participants from the Centenarian Family Registry established at the American Federation for Aging Research (AFAR). The program builds gerontology community awareness about the study using multi-modal engagement methods.
Researchers also use email outreach to invite enrollees in the AFAR Centenarian Family Registry, who agree to receive information about research or other initiatives to participate in the research study.
The study team also targets the offspring of centenarians, which is a population familiar with mobile and computer technologies and motivated to reach out to their centenarian parent and to participate in research themselves.
The study team sends messages that include:
As a benefit of participation in the research study, participants can choose whether or not to receive information about their ancestry. Participants can access this data within the Participant Experience Manager portal.
All study tools that run on the Vibrent platform adhere to the Federal Information Security Management act of 2002 (FISMA), the Federal Risk and Authorization Management Program (FedRAMP), and Defense Information Systems Agency (DISA) guidelines.
The older an individual becomes, the more extreme is the longevity phenotype. Age 85 years is beyond the average life expectancy, but age 90 years is closer to the 90th percentile. Age 100 years is beyond the 99th percentile for contemporary birth cohorts. While not immune to age-related conditions, studying these individuals offers the promise of discovering genetic factors that impact the speed at which humans age.
A deeper understanding of biological and social determinants of healthy aging and exceptional longevity determinants could lead to novel strategies to delay aging and the chronic diseases associated with aging. This would: